Diabetes pill shows Real-World results in finnish patients
NCT ID NCT05443191
Summary
This study observed how the oral medication Rybelsus (semaglutide) works for people with type 2 diabetes in everyday life. Researchers followed 50 adults in Finland for 8-10 months to see how well the drug controlled their blood sugar and affected their weight. The goal was to collect real-world information on the medication's effectiveness and patient satisfaction.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aava Lääkärikeskus Kamppi
Helsinki, 00100, Finland
-
Master Centre for Finland
Helsinki, Finland, 00100, Finland
-
Master centre for France_Paris La défense cedex
Paris, La Défense, cedex, France
Conditions
Explore the condition pages connected to this study.